This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1984 Oct 6;2(8406):809-10.

doi: 10.1016/s0140-6736(84)90729-3.

High-dose intravenous gammaglobulin for myasthenia gravis

G Ippoliti¹, V Cosi, G Piccolo, M Lombardi, R Mantegaz

Affiliations

PMID: 6148545
DOI: 10.1016/s0140-6736(84)90729-3

Case Reports

High-dose intravenous gammaglobulin for myasthenia gravis

G Ippoliti et al. Lancet. 1984.

. 1984 Oct 6;2(8406):809-10.

doi: 10.1016/s0140-6736(84)90729-3.

Authors

G Ippoliti¹, V Cosi, G Piccolo, M Lombardi, R Mantegaz

Affiliation

¹ Medical Clinic 1, University of Pavia, 27100 Pavia, Italy.

PMID: 6148545
DOI: 10.1016/s0140-6736(84)90729-3

No abstract available

PubMed Disclaimer

Similar articles

High-dose intravenous gammaglobulin for myasthenia gravis.
Fateh-Moghadam A, Wick M, Besinger U, Geursen RG. Fateh-Moghadam A, et al. Lancet. 1984 Apr 14;1(8381):848-9. doi: 10.1016/s0140-6736(84)92294-3. Lancet. 1984. PMID: 6200741 Clinical Trial. No abstract available.
[High doses of intravenous gamma globulin in the treatment of myasthenia gravis].
Fort López-Barajas JM, Ponseti Bosch JM. Fort López-Barajas JM, et al. Med Clin (Barc). 1988 Sep 24;91(9):325-8. Med Clin (Barc). 1988. PMID: 3216754 Spanish. No abstract available.
[A case of intractable myasthenia gravis treated with cyclosporine and high-dose intravenous immunoglobulin].
Sato A, Katsui T, Honma A, Koike R, Tanaka M, Tanaka K, Tsuji S. Sato A, et al. Nihon Naika Gakkai Zasshi. 1996 Feb 10;85(2):279-81. Nihon Naika Gakkai Zasshi. 1996. PMID: 8708459 Japanese. No abstract available.
Experience with intravenous immunoglobulin in myasthenia gravis: a review.
Edan G, Landgraf F. Edan G, et al. J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):55-6. doi: 10.1136/jnnp.57.suppl.55. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964855 Free PMC article. Review. No abstract available.
High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
Ferrero B, Durelli L. Ferrero B, et al. Neurol Sci. 2002 Apr;23 Suppl 1:S9-24. doi: 10.1007/s100720200011. Neurol Sci. 2002. PMID: 12032583 Review.

See all similar articles

Cited by

High-dose intravenous immunoglobulin in myasthenia gravis.
Evoli A, Palmisani MT, Bartoccioni E, Padua L, Tonali P. Evoli A, et al. Ital J Neurol Sci. 1993 Apr;14(3):233-7. doi: 10.1007/BF02335664. Ital J Neurol Sci. 1993. PMID: 8314677
High-dose intravenous gamma-globulin therapy for myasthenia gravis.
Ibars IB, Ponseti J, Español T, Matias-Guiu J, Codina-Puiggros A. Ibars IB, et al. J Neurol. 1987 Jun;234(5):363. doi: 10.1007/BF00314298. J Neurol. 1987. PMID: 3612211 No abstract available.
Basic principles of intravenous immunoglobulin (IVIg) treatment.
Stangel M, Pul R. Stangel M, et al. J Neurol. 2006 Sep;253 Suppl 5:V18-24. doi: 10.1007/s00415-006-5003-1. J Neurol. 2006. PMID: 16998749 Review.
The clinical use of intravenous immunoglobulin in pediatrics.
Wahn V. Wahn V. Indian J Pediatr. 1987 Sep-Oct;54(5):641-53. doi: 10.1007/BF02751271. Indian J Pediatr. 1987. PMID: 3428982 No abstract available.
Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.
Jacob S, Rajabally YA. Jacob S, et al. Curr Neuropharmacol. 2009 Dec;7(4):337-42. doi: 10.2174/157015909790031166. Curr Neuropharmacol. 2009. PMID: 20514213 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information